The global coronary stents market is set for steady expansion, rising from USD 37.5 billion in 2026 to USD 64.6 billion by 2036, reflecting a compound annual growth rate (CAGR) of 5.6%. Future Market Insights highlights that this trajectory is driven by the enduring worldwide prevalence of coronary artery disease and ongoing improvements in percutaneous coronary intervention (PCI) techniques. With cardiovascular diseases continuing as a major global health challenge, demand remains strong for advanced revascularization solutions like drug-eluting stents and emerging bioresorbable platforms.

Read Full Report:https://www.futuremarketinsights.com/reports/coronary-stents-market

Market snapshot: global market 2026 - 2036

  • Market size in 2026? USD 37.5 billion.
  • Market size in 2036? USD 64.6 billion.
  • CAGR (2026–2036)? 5.6%.
  • Leading product segment(s) and shares? Drug-Eluting Stents (DES) hold the leading position, accounting for 33.2% market share in 2025.
  • Leading material type and share? Not specified in detail; common materials include Cobalt-Chromium, Platinum-Chromium, Stainless Steel, and PLLA Bioresorbable.
  • Leading end use and share? Hospitals dominate with 27.1% market share in 2025.
  • Key growth regions? United States (largest share), emerging high-volume markets (e.g., India prioritized for launches), Europe (fast-growing with advanced systems).
  • Top companies? Boston Scientific Corporation, Abbott Laboratories, Medtronic, MicroPort, Terumo Corporation, B. Braun Melsungen AG, BIOTRONIK SE & Co. KG.

Market Momentum (YoY Path) The coronary stents market follows a consistent upward path through the forecast period. Starting at USD 37.5 billion in 2026, the market demonstrates measured annual gains driven by rising PCI volumes and adoption of next-generation platforms. Key milestone values include progressive increases toward USD 64.6 billion by 2036, with the trajectory reflecting stable demand from the persistent burden of coronary artery disease and incremental technological refinements.

Why the Market is Growing The coronary stents market benefits from the high global prevalence of cardiovascular diseases, which fuels demand for minimally invasive procedures such as PCI. Risk factors including poor diet, smoking, sedentary lifestyles, and stress contribute to millions of annual deaths, sustaining the need for effective revascularization devices. Technological advancements further accelerate momentum, with innovations in stent design—such as drug-eluting stents that reduce restenosis risks and bioresorbable scaffolds that dissolve after supporting vessel healing—delivering improved patient outcomes and clinician confidence.

Segment Spotlight

Product Type Drug-Eluting Stents (DES) lead the coronary stents market, commanding a 33.2% share in 2025. These stents release medication to prevent scar tissue formation and restenosis, making them particularly effective in complex cases and challenging anatomies where traditional options fall short.

Material Type Materials such as Cobalt-Chromium, Platinum-Chromium, Stainless Steel, and PLLA Bioresorbable underpin the coronary stents market. Bioresorbable options stand out for their temporary vessel support followed by natural dissolution, addressing long-term concerns associated with permanent implants and supporting improved arterial recovery.

End Use Hospitals capture 27.1% of the coronary stents market in 2025, serving as the primary setting due to their advanced cardiology facilities, specialized teams, and comprehensive post-procedure care. These environments enable complex interventions and ongoing patient management essential for optimal outcomes.

Drivers, Opportunities, Trends, Challenges

Drivers High prevalence of cardiovascular diseases drives demand for minimally invasive coronary interventions worldwide. Technological progress in areas like drug-eluting stents, biodegradable stents, and advanced imaging (e.g., OCT) enhances procedural accuracy and patient safety.

Opportunities The re-emergence of bioresorbable vascular scaffolds presents significant potential, particularly in complex lesion applications. Prioritization of high-volume emerging markets for new launches, alongside continued R&D in next-generation platforms, opens pathways for expanded adoption.

Trends Key trends in the coronary stents market include the increasing acceptance of bioabsorbable stents that provide temporary support before dissolving, eliminating permanent foreign material and reducing risks like chronic inflammation or late thrombosis. Ultra-low-profile DES platforms target complex anatomies, while companies focus on emerging markets for faster introductions.

Challenges Stringent regulatory processes from bodies like the FDA, EMA, and CDSCO require extensive clinical trials, raising compliance costs and delaying launches. High pricing of advanced stents, combined with reimbursement limitations and healthcare disparities in rural or underserved areas, restricts accessibility and slows broader adoption of innovative technologies.

Subscribe for Year-Round Insights → Stay ahead with quarterly and annual data updates:https://www.futuremarketinsights.com/reports/brochure/rep-gb-1993

Get Access of Report Sample: https://www.futuremarketinsights.com/reports/sample/rep-gb-1993

Competitive Landscape

The coronary stents market features established leaders investing heavily in innovation. Key players include Boston Scientific Corporation (strong interventional cardiology performance), Abbott Laboratories (XIENCE Sierra platform), Medtronic (Resolute Onyx), MicroPort (Firesorb BVS launch), Terumo Corporation, B. Braun Melsungen AG, BIOTRONIK, and others. Recent activity highlights new product introductions and advancements in bioresorbable technology.

FAQ

What is the growth outlook for the coronary stents market according to Future Market Insights? Future Market Insights projects the coronary stents market to expand at a CAGR of 5.6% from 2026 to 2036, growing from USD 37.5 billion in 2026 to USD 64.6 billion by 2036.

How do FMI analysts view the evolution of the coronary stents market? FMI analysts see the market moving toward a dual-platform structure, with metallic drug-eluting stents remaining the high-volume standard and bioresorbable scaffolds gaining traction in select complex applications.

Which country holds the largest share in the global coronary stents market? The United States maintains a significant share, supported by high per-capita PCI rates and favorable reimbursement for advanced DES platforms.

How large will the coronary stents market be by 2036? The global coronary stents market is projected to reach USD 64.6 billion by 2036.

What is included in the coronary stents market definition? The coronary stents market covers revenue from drug-eluting stents (DES), bare-metal stents (BMS), and bioresorbable vascular scaffolds (BVS) used in PCI for coronary artery disease treatment.

Explore More Related Studies Published by FMI Research:

Radiology Drainage Catheters Market: https://www.futuremarketinsights.com/reports/radiology-drainage-catheters-market

Digital Health for Obesity Market: https://www.futuremarketinsights.com/reports/digital-health-for-obesity-market

Companion Animal Imaging Market: https://www.futuremarketinsights.com/reports/companion-animal-imaging-market

PARP Inhibitor Market: https://www.futuremarketinsights.com/reports/parp-inhibitors-market

Demand for Stent Graft Balloon Catheter in Japan: https://www.futuremarketinsights.com/reports/japan-stent-graft-balloon-catheter-market

About Future Market Insights (FMI)

 Future Market Insights, Inc. (FMI) is an ESOMAR-certified, ISO 9001:2015 market research and consulting organization, trusted by Fortune 500 clients and global enterprises. With operations in the U.S., UK, India, and Dubai, FMI provides data-backed insights and strategic intelligence across 30+ industries and 1200 markets worldwide.

Why FMI: Decisions that Change Outcomes- https://www.futuremarketinsights.com/why-fmi

Contact Us:    

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Have a specific Requirements and Need Assistant on Report Pricing or Limited Budget please contact us - sales@futuremarketinsights.com